Dr. Walter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-454-8304Fax+1 314-454-5902
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1998 - 2002
- Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
- Saint Louis University School of MedicineClass of 1995
Certifications & Licensure
- MO State Medical License 2003 - 2025
- IL State Medical License 2020 - 2023
- MD State Medical License 1999 - 2001
- American Board of Internal Medicine Hematology
Clinical Trials
- Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2009 May 05
- Carfilzomib, Pegylated Liposomal Doxorubicin Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2012 May 14
- Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation Start of enrollment: 2013 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- 3105 citationsMutational landscape and significance across 12 major cancer typesCyriac Kandoth, Michael D. McLellan, Fabio Vandin, Kai Ye, Beifang Niu
Nature. 2013-10-17 - 142 citationsCpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML ProgressionDavid H. Spencer, David A. Russler-Germain, Shamika Ketkar, Nichole M. Helton, Tamara Lamprecht
Cell. 2017-02-23 - 3500 citationsGenomic and epigenomic landscapes of adult de novo acute myeloid leukemiaTimothy J. Ley, Christopher A. Miller, Li Ding, Benjamin J. Raphael, Andrew J. Mungall
The New England Journal of Medicine. 2013-05-30
Journal Articles
- Discriminating a Common Somatic ASXL1 Mutation (c.1934dup; p.G646Wfs*12) from Artifact in Myeloid Malignancies Using NGSJonathan W Heusel, Richard D Press, Matthew J Walter, Eric J Duncavage, Nature
Abstracts/Posters
- Mutant U2AF1S34F and U2AF1Q157P Induce Distinct RNA Splicing and Hematopoietic Phenotypes In VivoMatthew J. Walter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS StudyMatthew J. Walter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Understanding and Targeting TP53 in Myeloid Malignancies61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Translating Pathophysiological Advances Into Innovative Treatments for Myelodysplastic Syndromes and Related Myeloid Neoplasms60th American Society of Hematology Annual Meeting - 11/30/2018
Press Mentions
- Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising InvestigatorsJuly 15th, 2021
- $5 Million Grant Endows Research to Advance Blood Disorder TherapiesSeptember 11th, 2019
- Washington University Medicine St. Louis: An Elite Investigative Hub for Acute Myeloid LeukemiaSeptember 3rd, 2019
- Join now to see all
Grant Support
- Genetics Of Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2011–2012
- Genetic Progression Events In Murine APLNational Heart, Lung, And Blood Institute2005–2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: